Clostridium difficile shows no trade-off between toxin and spore production within the human host

被引:6
作者
Blanco, Natalia [1 ]
Walk, Seth [2 ]
Malani, Anurag N. [3 ]
Rickard, Alexander [1 ]
Benn, Michele [4 ]
Eisenberg, Marisa [1 ]
Zhang, Min [3 ,5 ]
Foxman, Betsy [1 ]
机构
[1] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA
[2] Montana State, Coll Letters & Sci, Dept Microbiol & Immunol, Bozeman, MT USA
[3] St Joseph Mercy Hlth Syst, Dept Infect Prevent & Control, Dept Internal Med, Div Infect Dis, Ann Arbor, MI USA
[4] St Joseph Mercy Hlth Syst, Microbiol Lab, Dept Pathol, Ann Arbor, MI USA
[5] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA
关键词
Clostridium difficile infection; toxin; spores; SEVERE INFECTION; MOLECULAR TEST; SPORULATION; RIBOTYPE; DISEASE; OVERGROWTH; METABOLISM; VANCOMYCIN; RELEVANCE; DIAGNOSIS;
D O I
10.1099/jmm.0.000719
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Purpose. This study aimed to describe the correlation between Clostridium difficile spore and toxin levels within the human host. In addition, we assessed whether overgrowth of Candida albicans modified this association. Methodology. We measured toxin, spore and Candida albicans levels among 200 successively collected stool samples that tested positive for C. difficile, and PCR ribotyped these C. difficile isolates. Analysis of variance and linear regression were used to test the association between spore and toxin levels. Kruskal-Wallis tests and t-tests were used to compare the association between spore or toxin levels and host, specimen, or pathogen characteristics. Results. C. difficile toxin and spore levels were positively associated (P<0.001); this association did not vary significantly with C. albicans overgrowth [<= 5 logs of C. albicans colony-forming units (c.f.u.) g(-1)]. However, ribotypes 027 and 078-126 were significantly associated with higher levels of toxin and spores, and C. albicans overgrowth. Conclusion. The strong positive association observed between in vivo levels of C. difficile toxin and spores suggests that patients with more severe C. difficile infections may have increased spore production, enhancing C. difficile transmission. Although, on average, spore levels were higher in toxin-positive samples than in toxin-negative/PCR-positive samples, spores were found in almost all toxin-negative samples. The ubiquity of spore production among toxin-negative and formed stool samples emphasizes the importance of following infection prevention and control measures for all C. difficile-positive patients during their entire hospital stay.
引用
收藏
页码:631 / 640
页数:10
相关论文
共 37 条
[1]   Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates [J].
Åkerlund, T ;
Svenungsson, B ;
Lagergren, Å ;
Burman, LG .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (02) :353-358
[2]   Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection [J].
Baker, I. ;
Leeming, J. P. ;
Reynolds, R. ;
Ibrahim, I. ;
Darley, E. .
JOURNAL OF HOSPITAL INFECTION, 2013, 84 (04) :311-315
[3]   Integration of metabolism and virulence in Clostridium difficile [J].
Bouillaut, Laurent ;
Dubois, Thomas ;
Sonenshein, Abraham L. ;
Dupuy, Bruno .
RESEARCH IN MICROBIOLOGY, 2015, 166 (04) :375-383
[4]   Reconsidering the Sporulation Characteristics of Hypervirulent Clostridium difficile BI/NAP1/027 [J].
Burns, David A. ;
Heeg, Daniela ;
Cartman, Stephen T. ;
Minton, Nigel P. .
PLOS ONE, 2011, 6 (09)
[5]   The diverse sporulation characteristics of Clostridium difficile clinical isolates are not associated with type [J].
Burns, David A. ;
Heap, John T. ;
Minton, Nigel P. .
ANAEROBE, 2010, 16 (06) :618-622
[6]   The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates [J].
Carlson, Paul E., Jr. ;
Walk, Seth T. ;
Bourgis, Alexandra E. T. ;
Liu, Melissa W. ;
Kopliku, Fatos ;
Lo, Eugene ;
Young, Vincent B. ;
Aronoff, David M. ;
Hanna, Philip C. .
ANAEROBE, 2013, 24 :109-116
[7]  
CDC, 2015, HEALTHC ASS INF HAIS
[8]   Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) [J].
Cohen, Stuart H. ;
Gerding, Dale N. ;
Johnson, Stuart ;
Kelly, Ciaran P. ;
Loo, Vivian G. ;
McDonald, L. Clifford ;
Pepin, Jacques ;
Wilcox, Mark H. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (05) :431-455
[9]   Burden of Clostridium difficile on the Healthcare System [J].
Dubberke, Erik R. ;
Olsen, Margaret A. .
CLINICAL INFECTIOUS DISEASES, 2012, 55 :S88-S92
[10]   Chemical and Stress Resistances of Clostridium difficile Spores and Vegetative Cells [J].
Edwards, Adrianne N. ;
Karim, Samiha T. ;
Pascual, Ricardo A. ;
Jowhar, Lina M. ;
Anderson, Sarah E. ;
McBride, Shonna M. .
FRONTIERS IN MICROBIOLOGY, 2016, 7